Comparative trials of RA 27-3 and Cendehill rubella vaccines in adult and adolescent females.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000906:Antibodies / Q000032:analysis*; D002648:Child; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007110:Immunity, Active; D007279:Injections, Subcutaneous; D009500:Neutralization Tests; D009666:Nose; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus / Q000302:isolation & purification; D012621:Seasons; D012996:Solutions; D014556:Urine / Q000382:microbiology; D014765:Viral Vaccines / Q000009:adverse effects*
D000906:Antibodies; D012411:Rubella Vaccine; D012996:Solutions; D014765:Viral Vaccines